JPRN-UMIN000016539已完成未知
THe effect of canagliflozin on active GLP-1 levels and betatrophin in patients with type 2 diabetes (CANARIA-STUDY) - THe effect of canagliflozin on active GLP-1 levels and betatrophin (CANARIA STUDY)
Dokkyo Medical University Koshigaya Hospital0 个研究点目标入组 40 人开始时间: 2015年2月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with type 1 diabetes, pancreatic diabetes or secondary diabetes (Cushing syndrome, acromegaly etc.) diabetic coma or diabetic pre-coma, or type 1 diabetes 2)Patients who are not candidated for canagliflozin or teneligliptin treatment 3)Patients under insulin treatment 4)Heavy alcohol consumer (more than or equal to 60 g/day of pure alcohol ) 5)Patients under pregnancy, possible pregnancy, or lactation 6)Patients with severe renal dysfunction (Cr >2.4 mg/dL or Ccr <30 mL/min) 7)Furthermore, patients judged as inadequacy for participation in this study by medical doctor
研究者
相似试验
已完成
不适用
Effects of canagliflozin on the glycemic control and plasma GLP-1 levels.Type 2 diabetes mellitusJPRN-UMIN000018345akakinen clinic45
已完成
不适用
Effect of SGLT2 inhibitor, canagliflozin, for the size of lipid particlesType 2 diabetesJPRN-UMIN000020027Tokyo Medical and Dental University Department of Medical Genetics / Gerontorgy30
已完成
不适用
The influence of GLP-1 receptor agonist on the heart rate using holter electrocardiography and power spectrum analysis on heart rate variabilityType 2 diabetesJPRN-UMIN000017770Dokkyomedical university nikko medical center50
进行中（未招募）
1 期
Effects of Linagliptin on active GLP-1 concentrations in subjects with renal impairmentEUCTR2013-000364-28-DEProfil Institut für Stoffwechselforschung GmbH
进行中（未招募）
1 期
A study to evaluate the effect of a licensed drug to lower blood glucose, liraglutide, on inflammation in patients with diabetic kidney disease.EUCTR2012-005482-12-IEniversity College Dublin